advertisement

---

Clinical Therapeutics 2

Showing records 1 to 2 | Display all abstracts in Clinical Therapeutics

14222 A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clinical Therapeutics 2006; 28: 552-559

---

14126 A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clinical Therapeutics 2006; 28: 332-339

---